Roman Melamed

Join critical care intensivist Roman Melamed, director of the Pulmonary Embolism Program at Abbott Northwestern Hospital, as he dives into the comparative effectiveness of reduced-dose versus full-dose alteplase for acute pulmonary embolism. Discover how both dosing strategies show promising patient outcomes, with reduced-dose treatments linked to fewer hemorrhagic complications. The discussion also touches on the impact of COVID-19 on vascular events, emphasizing the need for ongoing research to refine treatment strategies for better patient care.